United States Ophthalmic Market 规模与份额分析 - 成长趋势与预测 (2023-2031)
United States Ophthalmic Market is Segmented By Drug Class (Anti-inflammatory Drugs, Anti-infective Drugs, Anti-glaucoma Drugs, Anti-VEGF Agents, and Others), By Dosage Form (Eye Drops, Ointments, Gels, Solutions, Injections, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Indication (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies). The report offers the value (in USD billion) for the above-mentioned segments.
Competitive overview of United States Ophthalmic Market
在美国眼科市场运营的主要角色包括诺华公司(Novartis AG),AbbVie,Merck & Co, Inc.,Bausch保健公司,Santen制药公司,Ltd.,Regeneron制药公司,Sun制药工业有限公司,Ocular Therapeutix, Inc.,Alcon,KALA BIO,Aequus制药公司,Omeros Corporation Takeda制药有限公司,Eynovia, Inc.,Nicox等知名角色.
United States Ophthalmic Market Leaders
- 诺华集团
- 阿布维
- 默克公司
- Bausch卫生公司
- 桑滕制药有限公司.
*Disclaimer: Major players are listed in no particular order.
United States Ophthalmic Market - Competitive Rivalry, 2023
United States Ophthalmic Market
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights